Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Accured Expenses: 2011-2025

Historic Change in Accured Expenses for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to $58,000.

  • Enanta Pharmaceuticals' Change in Accured Expenses rose 502.99% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58,000, marking a year-over-year increase of 101.03%. This contributed to the annual value of $58,000 for FY2025, which is 101.03% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Change in Accured Expenses of $58,000 as of FY2025, which was up 101.03% from -$5.6 million recorded in FY2024.
  • Enanta Pharmaceuticals' 5-year Change in Accured Expenses high stood at $8.3 million for FY2021, and its period low was -$5.6 million during FY2024.
  • Moreover, its 3-year median value for Change in Accured Expenses was -$2.6 million (2023), whereas its average is -$2.7 million.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Change in Accured Expenses spiked by 710.38% in 2021 and then crashed by 120.72% in 2024.
  • Enanta Pharmaceuticals' Change in Accured Expenses (Yearly) stood at $8.3 million in 2021, then plummeted by 117.69% to -$1.5 million in 2022, then crashed by 73.19% to -$2.6 million in 2023, then slumped by 120.72% to -$5.6 million in 2024, then surged by 101.03% to $58,000 in 2025.